Serveur d'exploration Stress et Covid

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Proteomic analysis of serum, plasma, and lymph for the identification of biomarkers

Identifieur interne : 002024 ( Main/Merge ); précédent : 002023; suivant : 002025

Proteomic analysis of serum, plasma, and lymph for the identification of biomarkers

Auteurs : Zhaojing Meng [États-Unis] ; Timothy D. Veenstra [États-Unis]

Source :

RBID : ISTEX:40BDA9A670C670D32C72CFED6C558622668F5AAF

Abstract

Probably no topic has generated more excitement in the world of proteomics than the search for biomarkers. This excitement has been generated by two realities: the constant need for better biomarkers that can be used for disease diagnosis and prognosis, and the recent developments in proteomic technologies that are capable of scanning the individual proteins within varying complex clinical samples. Ideally a biomarker would be assayable from a noninvasively collected sample, therefore, much of the focus in proteomics has been on the analysis of biofluids such as serum, plasma, urine, cerebrospinal fluid, lymph, etc. While the discovery of biomarkers has been elusive, there have been many advances made in the understanding of the proteome content of various biofluids, and in the technologies used for their analysis, that continues to point the research community toward new methods for achieving the ultimate goal of identifying novel disease‐specific biomarkers. In this review, we will describe and discuss many of the proteomic approaches taken in an attempt to find novel biomarkers in serum, plasma, and lymph.

Url:
DOI: 10.1002/prca.200700243

Links toward previous steps (curation, corpus...)


Links to Exploration step

ISTEX:40BDA9A670C670D32C72CFED6C558622668F5AAF

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Proteomic analysis of serum, plasma, and lymph for the identification of biomarkers</title>
<author>
<name sortKey="Meng, Zhaojing" sort="Meng, Zhaojing" uniqKey="Meng Z" first="Zhaojing" last="Meng">Zhaojing Meng</name>
</author>
<author>
<name sortKey="Veenstra, Timothy D" sort="Veenstra, Timothy D" uniqKey="Veenstra T" first="Timothy D." last="Veenstra">Timothy D. Veenstra</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:40BDA9A670C670D32C72CFED6C558622668F5AAF</idno>
<date when="2007" year="2007">2007</date>
<idno type="doi">10.1002/prca.200700243</idno>
<idno type="url">https://api.istex.fr/ark:/67375/WNG-W0ZTV7G3-D/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000515</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000515</idno>
<idno type="wicri:Area/Istex/Curation">000515</idno>
<idno type="wicri:Area/Istex/Checkpoint">000D00</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000D00</idno>
<idno type="wicri:doubleKey">1862-8346:2007:Meng Z:proteomic:analysis:of</idno>
<idno type="wicri:Area/Main/Merge">002024</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main">Proteomic analysis of serum, plasma, and lymph for the identification of biomarkers</title>
<author>
<name sortKey="Meng, Zhaojing" sort="Meng, Zhaojing" uniqKey="Meng Z" first="Zhaojing" last="Meng">Zhaojing Meng</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Laboratory of Proteomics and Analytical Technologies, SAIC‐Frederick Inc., National Cancer Institute at Frederick, Frederick, MD</wicri:regionArea>
<placeName>
<region type="state">Maryland</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Veenstra, Timothy D" sort="Veenstra, Timothy D" uniqKey="Veenstra T" first="Timothy D." last="Veenstra">Timothy D. Veenstra</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Laboratory of Proteomics and Analytical Technologies, SAIC‐Frederick Inc., National Cancer Institute at Frederick, Frederick, MD</wicri:regionArea>
<placeName>
<region type="state">Maryland</region>
</placeName>
</affiliation>
<affiliation></affiliation>
<affiliation></affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j" type="main">PROTEOMICS – Clinical Applications</title>
<title level="j" type="sub">PROTEOMIC ANALYSIS OF BIOLOGICAL FLUIDS</title>
<title level="j" type="alt">PROTEOMICS CLINICAL APPLICATIONS</title>
<idno type="ISSN">1862-8346</idno>
<idno type="eISSN">1862-8354</idno>
<imprint>
<biblScope unit="vol">1</biblScope>
<biblScope unit="issue">8</biblScope>
<biblScope unit="page" from="747">747</biblScope>
<biblScope unit="page" to="757">757</biblScope>
<biblScope unit="page-count">11</biblScope>
<publisher>WILEY‐VCH Verlag</publisher>
<pubPlace>Weinheim</pubPlace>
<date type="published" when="2007-08">2007-08</date>
</imprint>
<idno type="ISSN">1862-8346</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">1862-8346</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Probably no topic has generated more excitement in the world of proteomics than the search for biomarkers. This excitement has been generated by two realities: the constant need for better biomarkers that can be used for disease diagnosis and prognosis, and the recent developments in proteomic technologies that are capable of scanning the individual proteins within varying complex clinical samples. Ideally a biomarker would be assayable from a noninvasively collected sample, therefore, much of the focus in proteomics has been on the analysis of biofluids such as serum, plasma, urine, cerebrospinal fluid, lymph, etc. While the discovery of biomarkers has been elusive, there have been many advances made in the understanding of the proteome content of various biofluids, and in the technologies used for their analysis, that continues to point the research community toward new methods for achieving the ultimate goal of identifying novel disease‐specific biomarkers. In this review, we will describe and discuss many of the proteomic approaches taken in an attempt to find novel biomarkers in serum, plasma, and lymph.</div>
</front>
</TEI>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/StressCovidV1/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002024 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 002024 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    StressCovidV1
   |flux=    Main
   |étape=   Merge
   |type=    RBID
   |clé=     ISTEX:40BDA9A670C670D32C72CFED6C558622668F5AAF
   |texte=   Proteomic analysis of serum, plasma, and lymph for the identification of biomarkers
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed May 6 16:44:09 2020. Site generation: Sun Mar 28 08:26:57 2021